Question 1

Is Insulin glargine currently in shortage?

Accepted Answer

Yes. As of the latest regulator updates, Insulin glargine has 31 active shortage notices across 10 countries (United States, Canada, European Union, New Zealand, Germany, Belgium and more). Status is refreshed daily from official regulatory sources.

Question 2

Why is Insulin glargine in shortage?

Accepted Answer

Regulators attribute the current Insulin glargine shortages to supply-chain disruption, causes not stated by the regulator, product discontinuation. The exact cause varies by country and product — each notice on this page links to the official source.

Question 3

When will the Insulin glargine shortage be resolved?

Accepted Answer

Regulator-estimated resolution dates currently range from 31 Jan 2025 to 31 Dec 2026, depending on country and product. These estimates come from the manufacturers via regulators and often change — check the per-country table above for the latest.

Question 4

What are the alternatives to Insulin glargine?

Accepted Answer

Mederti lists 6 drugs in the same WHO ATC class as Insulin glargine (see above). These are classification context only — not clinically reviewed substitutes. Always confirm any switch with a pharmacist or prescriber and your national guidance.

Question 5

Where does this Insulin glargine shortage data come from?

Accepted Answer

Every shortage notice on this page is scraped daily from an official national medicines regulator (such as the FDA, TGA, MHRA or EMA) and linked back to its source. Mederti aggregates 40+ official regulators across 35+ countries and never publishes unsourced shortage claims.

Insulin glargine shortage status

Where Insulin glargine is in shortage

Why Insulin glargine is in shortage

Drugs in the same class as Insulin glargine

Recent shortage history

Frequently asked questions

Related medicines

Get alerted when Insulin glargine status changes